Yuliang Jiang Selected Research

Iodine-125

11/2021	PD-1 Inhibitor Maintenance Therapy Combined Iodine-125 Seed Implantation Successfully Salvage Recurrent Cervical Cancer after CCRT: A Case Report.
8/2021	3D-printed template and optical needle navigation in CT-guided iodine-125 permanent seed implantation.
6/2021	The accuracy and dosimetric analysis of 3D-printing non-coplanar template-assisted iodine-125 seed implantation for recurrent chest wall cancer.
2/2021	Accuracy and dosimetric parameters comparison of 3D-printed non-coplanar template-assisted computed tomography-guided iodine-125 seed ablative brachytherapy in pelvic lateral recurrence of gynecological carcinomas.
2/2021	Dosimetric comparison of computed tomography-guided iodine-125 seed implantation assisted with and without three-dimensional printing non-coplanar template in locally recurrent rectal cancer: a propensity score matching study.
1/2021	Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions.
11/2020	The accuracy and safety of CT-guided iodine-125 seed implantation assisted by 3D non-coplanar template for retroperitoneal recurrent carcinoma.
1/2020	Safety and efficacy of CT-guided radioactive iodine-125 seed implantation assisted by a 3D printing template for the treatment of thoracic malignancies.
10/2019	Radiation-related Adverse Effects of CT-guided Implantation of 125I Seeds for Thoracic Recurrent and/or Metastatic Malignancy.
2/2011	Image-guided percutaneous (125)I seed implantation as a salvage treatment for recurrent soft tissue sarcomas after surgery and radiotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuliang Jiang Research Topics

Disease

20	Neoplasms (Cancer) 11/2021 - 02/2011
6	Carcinoma (Carcinomatosis) 02/2021 - 06/2010
5	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2017
4	Rectal Neoplasms (Rectal Cancer) 05/2021 - 01/2020
3	Lymphatic Metastasis 05/2020 - 09/2015
3	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 02/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 03/2013
3	Pain (Aches) 01/2019 - 09/2015
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021 - 01/2019
2	Carcinogenesis 01/2018 - 04/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013 - 06/2009
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 03/2019
1	Inflammation (Inflammations) 03/2019
1	Neuroinflammatory Diseases 03/2019
1	Xerostomia 02/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Hyperhomocysteinemia 01/2016
1	Wounds and Injuries (Trauma) 04/2015
1	Esophageal Squamous Cell Carcinoma 04/2015
1	Stomach Neoplasms (Stomach Cancer) 04/2015
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2015
1	Spinal Neoplasms 12/2014
1	Exfoliative Dermatitis (Erythroderma) 07/2013

Drug/Important Bio-Agent (IBA)

11	Iodine-125IBA 11/2021 - 06/2009
4	Polysaccharides (Glycans)IBA 01/2020 - 01/2018
3	Tn antigenIBA 01/2019 - 01/2018
2	SurvivinIBA 11/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2017 - 04/2015
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	TetraspaninsIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 11/2019
1	Radioisotopes (Radionuclides)IBA 10/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2019
1	diosmetinIBA 03/2019
1	NF-kappa B (NF-kB)IBA 03/2019
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	MucinsIBA 01/2018
1	vasectrin IIIIBA 01/2017
1	RNA IIBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	NADP TranshydrogenasesIBA 01/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	LigandsIBA 01/2016
1	Chemokine CXCL12IBA 01/2016
1	Bone Morphogenetic Protein 2IBA 04/2015
1	IodineIBA 12/2014

Therapy/Procedure

19	Radiotherapy 08/2021 - 02/2011
11	Brachytherapy 11/2021 - 12/2014
9	Salvage Therapy 01/2021 - 02/2011
5	Therapeutics 11/2021 - 06/2010
2	Re-Irradiation 01/2016 - 09/2015
2	Combined Modality Therapy 12/2015 - 04/2015
2	Laparotomy 12/2013 - 06/2009
1	Adjuvant Chemotherapy 11/2021
1	Chemoradiotherapy 11/2021
1	Punctures 08/2021
1	Self Expandable Metallic Stents 01/2021
1	Palliative Care (Palliative Therapy) 01/2018
1	Minimally Invasive Surgical Procedures 01/2018
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2015
1	Retreatment 12/2014
1	Nephrectomy 07/2013
1	Nephrotomy 07/2013